Caltrate ® – Pfizer Consumer Healthcare

Osteoporosis affects over 50% of New Zealand women aged over 60 years.¹⁰
Bone mass usually peaks in your 20s⁵. From then it will slowly decline with age.
Including adequate calcium in you diet will help to reduce your risk of developing osteoporosis.
National Nutritional Surveys have shown that a large proportion of New Zealanders do not have sufficient levels of calcium in their diet.⁶
Caltrate assists in preventing and treating osteoporosis.
Each Caltrate tablet contains 600mg of calcium or up to 60% of your recommended daily calcium intake.¹

References
1. National Health and Medical Research Council (2006). Nutrient Reference Values for Australia and New Zealand.
6. New Zealand Ministry of Health (1999). NZ Food: NZ People. Key Results of the 1997 National Nutrition Survey.
10. Osteoporosis New Zealand Inc (2010). What is Osteoporosis? Accessed 2 September 2010 from www.bones.org.nz

Caltrate is a medicine. Only Caltrate 600mg with Vitamin D is indicated to assist in preventing and treating osteoporosis. Medicines have benefits and some may have risks. Always read the label. Use only as directed. If symptoms persist see your healthcare professional. Caltrate Plus is a dietary supplement. Vitamins are supplementary to and should not replace a balanced diet.
Only Caltrate 600mg with vitamin D are indicated to assist in preventing and treating osteoporosis.

Pfizer Consumer Healthcare ©2010.
Privacy Policy | Terms of Use
This site is intended only for residents of New Zealand.
The information on this website does not replace the individual advice and consultation of a doctor or pharmacist.
Last updated March 2011.
TAPS Approval Number: CH2777.